Long‐Term Impact of Guselkumab on Skin, Sexuality, and Perceived Stigmatization in Patients With Psoriasis in Routine Clinical Practice: Week 76 Effectiveness and Safety Results From the Prospective German Multicenter G‐ <scp>EPOSS</scp> Study

20251 citationsJournal Articlehybrid Open Access

Authors

Sascha Gerdes · Clinical Research Center Kiel

Peter Weisenseel · Dermatologikum Hamburg

Durdana Groß · Krankenhaus Düren

Rolf Ostendorf · Städtische Kliniken Mönchengladbach

Sebastian Zimmer · Hasomed (Germany)

Alexander Otto · InLeaVe

Friedemann Taut ·

Abstract

Guselkumab treatment provided sustained improvements over 76 weeks in psoriasis, sexual impairment, QoL, and perceived stigmatization, irrespective of BMI, age, disease duration, sex, presence of anogenital psoriasis, or depression.

Topics & Keywords

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Asthma and respiratory diseases

Publication Details

Published in: The Journal of Dermatology

Volume 52, Issue 9, pp. 1368-1381

DOI: 10.1111/1346-8138.17866

Field-Weighted Citation Impact: 0.84

Command Palette

Long‐Term Impact of Guselkumab on Skin, Sexuality, and Perceived Stigmatization in Patients With Psoriasis in Routine Clinical Practice: Week 76 Effectiveness and Safety Results From the Prospective German Multicenter G‐ <scp>EPOSS</scp> Study

Authors

Abstract

Topics & Keywords

Publication Details